SCHEMBL10322254

SCHEMBL10322254

CC(C)(C)OC(=O)NCCC(Nc1cccc(-c2nn(COCC[Si](C)(C)C)c3nc(NCCN4CCOCC4)ncc23)n1)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MERTK Q12866 7/20 0.42
▸ AXL P30530 1/20 0.39
▸ TYRO3 Q06418 1/20 0.39
▸ DYRK1A Q13627 2/20 0.38
▸ DYRK1B Q9Y463 2/20 0.38
▸ BRD4 O60885 1/20 0.35
▸ CSNK2A1 P68400 1/20 0.34
▸ RIPK1 Q13546 1/20 0.34
▸ RIPK3 Q9Y572 1/20 0.34
▸ MAPK8 P45983 1/20 0.34
▸ LCK P06239 1/20 0.34
▸ KDR P35968 1/20 0.34
▸ JAK3 P52333 1/20 0.34
▸ MAPK14 Q16539 1/20 0.34
▸ TNK2 Q07912 1/20 0.33
▸ CCNA2 P20248 1/20 0.33
▸ CDK2 P24941 1/20 0.33
▸ CCNA1 P78396 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ CASR P41180 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10323335 0.89 MERTK (0.46) MERTKAXLTYRO3DYRK1ADYRK1B
SCHEMBL10322433 0.85 MERTK (0.36) MERTKAXLTYRO3MAPK8MAPK1
SCHEMBL10322741 0.82 MERTK (0.49) MERTKAXLTYRO3DYRK1ADYRK1B
SCHEMBL10322901 0.78 FLT3 (0.46) MERTKAXLTYRO3MAPK8TNK2
SCHEMBL10323052 0.78 MERTK (0.44) MERTKAXLTYRO3MAPK8JAK3
SCHEMBL10321987 0.77 MERTK (0.49) MERTKAXLTYRO3MAPK8TNK2
SCHEMBL10323111 0.77 FLT3 (0.47) MERTKAXLTYRO3MAPK8JAK3
SCHEMBL10322157 0.77 MERTK (0.43) MERTKAXLTYRO3MAPK8JAK3
SCHEMBL10323692 0.77 MERTK (0.65) MERTKAXLTYRO3TNK2
SCHEMBL10322732 0.76 DYRK1A (0.55) MERTKDYRK1ADYRK1BCSNK2A1RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362023-B2 Pyrazolo pyrimidines HOFFMANN-LA ROCHE INC. (US) 2013-01-29 — — US disclosed
WO-2012098068-A1 PYRAZOLO PYRIMIDINES AS DYRK1A AND DYRK1B INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
US-20120184508-A1 PYRAZOLO PYRIMIDINES BIODURO (BEIJING) COMPANY LTD. (CN) 2012-07-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120184508-A1 PYRAZOLO PYRIMIDINES TYMS, TYMP, TP53 MERTK 2006/4885AXL 1246/4885TYRO3 1985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback